Gastrointestinal Events and Osteoporosis Treatment Initiation published by Dove Medical Press
ClinicoEconomics and Outcomes Research has published the original research “Gastrointestinal events and association with initiation of treatment for osteoporosis”.
GI events after osteoporosis diagnosis were associated with a decreased likelihood of osteoporosis treatment initiation and an increased likelihood of treatment initiation with a non-bisphosphonate versus a bisphosphonate.
As corresponding author Dr Ankita Modi says “Pre-existing gastrointestinal events may deter the use of pharmacological treatment in patients diagnosed with osteoporosis. Based on a large US managed care database, women aged 55 years or older with osteoporosis diagnosis were studied. In this population of US women diagnosed with osteoporosis, a majority (64.3%) received no osteoporosis medication in the year following their osteoporosis diagnosis.”
Dr Modi continues “Gastrointestinal events after osteoporosis diagnosis were associated with a decreased likelihood of osteoporosis treatment initiation and among patients who initiated treatment, gastrointestinal events were associated with an increased likelihood of treatment initiation with non-bisphosphonates versus bisphosphonates”
As Professor Giorgio Colombo, Editor-in-Chief, explains “Pre-existing gastrointestinal events may deter the use of pharmacological treatment in patients diagnosed with osteoporosis. This study examine the association between pre-existing gastrointestinal events and osteoporosis, pharmacotherapy initiation among women diagnosed with osteoporosis, through claims data from a large US managed care database.”
ClinicoEconomics and Outcomes Research is an international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage.
Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
Updated 4 December 2015